GCM
STIM icon

Ghisallo Capital Management’s Neuronetics STIM Stock Holding History

Ghisallo Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-400,000
Closed -$1.47M – 194
2025
Q1 		$1.47M Buy
+400,000
New +$1.46M 0.13% 87

Other funds holding STIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Ghisallo Capital Management's STIM Position: Q2 2025 in Review

Ghisallo Capital Management sold out of Neuronetics (STIM) in Q2 2025, closing a stake of 400,000 shares — an estimated $1.47M sold.

Ghisallo Capital Management first reported a position in STIM in Q1 2025 and held it in 1 quarter. The position peaked at $1.47M in Q1 2025. 90 funds tracked by Wall St. Rank hold STIM as of Q2 2025.

  • Ghisallo Capital Management reported no remaining Neuronetics position as of Q2 2025 after selling out during the quarter.
  • Ghisallo Capital Management sold 400,000 Neuronetics shares in Q2 2025, an estimated $1.47M.
  • Ghisallo Capital Management first reported a position in Neuronetics in Q1 2025 and held it in 1 quarter.
  • Ghisallo Capital Management's Neuronetics position peaked at $1.47M in Q1 2025.
  • 90 funds tracked by Wall St. Rank held Neuronetics as of Q2 2025.

Based on Ghisallo Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.